Chemical Component Summary

Name ACETOHYDROXAMIC ACID
Identifiers N-hydroxyacetamide
N-hydroxyethanamide
Formula C2 H5 N O2
Molecular Weight 75.07 g/mol
Type non-polymer
Isomeric SMILES CC(=O)NO
InChI InChI=1S/C2H5NO2/c1-2(4)3-5/h5H,1H3,(H,3,4)
InChI Key RRUDCFGSUDOHDG-UHFFFAOYSA-N

Chemical Details

Formal Charge 0
Atom Count 10
Chiral Atom Count 0
Chiral Atoms
Bond Count 9
Aromatic Bond Count 0

Drug Info: DrugBank

DrugBank ID DB00551   (Stereoisomeric match)
Name Acetohydroxamic Acid
Groups approved
Description Acetohydroxamic Acid, a synthetic drug derived from hydroxylamine and ethyl acetate, is similar in structure to urea. In the urine, it acts as an antagonist of the bacterial enzyme urease. Acetohydroxamic Acid has no direct antimicrobial action and does not acidify urine directly. It is used, in addition to antibiotics or medical procedures, to treat chronic urea-splitting urinary infections.
Synonyms
  • Acethydroxamsaeure
  • Acethydroxamsaure
  • Acetic acid, oxime
  • Acetohydroxamate
  • Acetohydroxamic acid
Brand Names Lithostat
Affected Organism Enteric bacteria and other eubacteria
Indication Used, in addition to antibiotics or medical procedures, to treat chronic urea-splitting urinary infections.
Pharmacology Acetohydroxamic Acid, a synthetic drug derived from hydroxylamine and ethyl acetate, is similar in structure to urea. In the urine, it acts as an antagonist of the bacterial enzyme urease. Acetohydroxamic Acid has no direct antimicrobial action and does not acidify urine directly.
Mechanism of action Acetohydroxamic Acid reversibly inhibits the bacterial enzyme urease. This inhibits the hydrolysis of urea and production of ammonia in urine infected with urea-splitting organisms, leading to a decrease in pH and ammonia levels. As antimicrobial agents are more effective in such conditions, the effectiveness of these agents is amplified, resulting in a higher cure rate.
Route of administration oral
Categories Enzyme Inhibitors
ATC-Code G04BX03
CAS number 546-88-3
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID: 21059682